✦ LIBER ✦

The pathway from amyloid to tau for aberrant neuronal cell cycle re-entry in Alzheimer's disease

✍ Scribed by Seward, Matthew; Swanson, Eric; Roberson, Erik; Bloom, George

Book ID: 123193879
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 54 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.1943

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beta-amyloid–induced cell cycle re-entry

Beta-amyloid–induced cell cycle re-entry in Alzheimer's disease is controlled by the Rac1-mTOR pathway

✍ Norambuena, Andres; Bloom, George 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P3-313: Pin1 deregulation in Alzheimer's

P3-313: Pin1 deregulation in Alzheimer's disease: A role in the aberrant cell cycle re-entry?

✍ Galas, Marie-Christine; Dourlen, Pierre; Ando, Kunié; Bégard, Séverine; Hamdane, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Aβ treatment and P301L tau expression in

Aβ treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry

✍ Frederic J. Hoerndli; Steven Pelech; Andreas Papassotiropoulos; Jürgen Götz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 1007 KB

Mutations in amyloid precursor protein a

Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β-peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease

✍ Hafiz Mohmmad Abdul; Rukhsana Sultana; Jeffrey N. Keller; Daret K St. Clair; Wil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Books of Interest Emerging Drugs and Tar

Books of Interest Emerging Drugs and Targets for Alzheimer’s Disease. Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 317 pp. 16 × 24 cm. ISBN 978-1-84973-063-1 . $249.00. Emerging Drugs and Targets for Alzheimer’s Disease. Volume 2: Neuronal Plasticity, Neuronal Protection and Other Miscellaneous Strategies . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 301 pp. 16 × 24 cm. ISBN 978-1-84973-064-8 . $249.00. Biopharmaceuticals in Plants. Toward the Next Century of Medicine . By Kathleen Laura Hefferon CRC Press , Boca Raton, FL . 2010 . xvii + 206 pp. 16 × 24 cm. ISBN 13 978-1-4398-0474-2 . $99.95. GPCR Molecular Pharmacology and Drug Targeting . Edited by Annette Gilchrist Wiley , Hoboken, NJ . 2010 . xxi + 520 pp. 16 × 24 cm. ISBN 978-0-470-30778-6 . $149.95. Drug Development Perspectives. Considerations, Challenges, and Strategies . Edited by Nuggehally R. Srinivas HNB Publishing , New York, NY . 2010 . x + 326 pp. 16 × 24 cm. ISBN 978-0-9664286-9-8 . $99.75. Chemoinformatics and Computational Chemical Biology . Edited by Jürgen Bajorath Humana Press/Springer Science , New York, NY . 2010 . x + 588 pp. 18.5 × 26 cm. ISBN 978-1-60761-838-6 . $159.00. Functional Molecules from Natural Sources . Edited by Stephen K. Wrigley , Robert Thomas , Colin T. Bedford , and Neville Nicholson Royal Society of Chemistry , Cambridge, U.K. 2011 . x + 233 pp. 16 × 24 cm. ISBN 978-1-84755-259-4 . £109.99.

📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 606 KB